301301SZSE

Announcement on the Use of Idle Funds to Purchase Financial Products by Yili Chuaning Biotechnology Co., Ltd. and Its Subsidiaries

Yili Chuannig Biotechnology Co., Ltd.·

✨ AI Summary

Yili Chuaning Biotechnology Co., Ltd. plans to use up to RMB 800 million of idle funds to invest in low-risk financial products over the next 12 months. The decision aims to enhance fund efficiency and generate returns without affecting normal operations. The board approved this investment strategy on March 27, 2026, ensuring strict risk control measures are in place.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Important Content Reminder:

  1. Investment Type: To control risks, the company and its subsidiaries will strictly evaluate and select low-risk, highly liquid financial products.
  2. Investment Amount: The total amount for short-term financial product investments will not exceed RMB 800 million. Funds can be rolled over within 12 months.
  3. Special Risk Reminder: The financial market is significantly influenced by macroeconomic factors, and risks include credit risk, liquidity risk, policy risk, force majeure, and unexpected events, which may affect returns and principal safety. Investors are advised to be cautious.

Yili Chuaning Biotechnology Co., Ltd. (hereinafter referred to as "the Company") held the 14th meeting of the second board of directors on March 27, 2026, and approved the proposal regarding the use of idle funds to purchase financial products. The relevant matters are announced as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing